Loading…
Equillium Inc Is A Biotechnology Innovator Developing Novel Therapies To Treat Severe Autoimmune And Inflammatory Disorders With The Mission To Develop Life-Changing Therapeutics For Patients. It Primary Goal Is To Advance Eq504, A Novel Aryl Hydrocarbon Receptor, Or Ahr, Modulator, Into And Through Clinical Development. The Company Operates Through A Single Operating And Reportable Segment Focused On The Business Of Developing Novel Therapies To Treat Severe Autoimmune And Inflammatory Disorders, With The Mission To Develop Life-Changing Therapeutics For Patients. The Company Manages All Business Activities On A Consolidated Basis.